期刊文献+

血浆TPS在肺部肿瘤诊断中的研究

Investigation of plasma TPS in lung tumor's diagnosis
下载PDF
导出
摘要 目的探讨血浆(肝素钠抗凝)作为标本检测TPS水平的可行性及血浆TPS水平对肺部肿瘤患者的诊断意义。方法采用ELISA法测定20例健康人血浆(肝素钠抗凝)和血清TPS水平,测定63例肺部肿瘤患者血浆TPS水平,采用ROC曲线确定血浆TPS的切割值,以其血清CEA值作为对照。结果健康人血浆和血清TPS水平差异无显著意义(P>0.05);肺癌患者血浆TPS水平明显高于肺部良性肿瘤患者(P<0.001);血浆TPS诊断肺癌灵敏度高于血清CEA(P<0.005),特异度比较差异无统计意义(P>0.05);同健康人相比较,肺部良性肿瘤组血浆TPS增高,差别具显著意义(P<0.01)。结论血浆(肝素钠抗凝)作为标本检测TPS水平有可行性;血浆TPS水平对于肺部肿瘤的诊断有意义,优于血清CEA。 Objective To explore the feasibility of detecting the TPS level using plasma sample, and the significance of the plasma TPS level in the diagnosis of lung tumor.Methods 20 healthy human plasma (heparin prevents clotting) and serum levels of the TPS were measured by enzyme linked immunosorbent assay (ELISA); 63 cases suffering lung tumor were included, whose plasma levels of TPS were measured. The cut-off value of preoperative plasma TPS was determined by using the ROC curve, serum CEA levels ascontrol. Results There was no significant difference between plasma and serum levels of the TPS in healthy people (P〉0.05);The plasma TPS levels in lung cancer patients were obviously higher than that in lung benign tumor patients (P〈0.001); There sensitivity of diagnosising lung tumor using plasma PTS was obviously higher than using serum CEA(P〈0.005), the contrast of specificity have no significant diference(P〉0.05) ;Compared with the healthy people, the plasma TPS levels in lung benign tumor patients were significantly higher (P〈0.01). Conclusion It is feasible to detect the levels of the TPS using plasma(heparin prevents clotting) as samples; Plasma TPS levels of preoperative lung tumor patients are meaningful for the diagnosis, better than using serum CEA.
出处 《江西医药》 CAS 2008年第9期892-894,共3页 Jiangxi Medical Journal
基金 江西省卫生厅科技计划
关键词 血浆 组织多肽特异性抗原 肺肿瘤 plasma tissue polypeptide specific antigen lung tumor
  • 相关文献

参考文献14

  • 1Ho YJ, Hsieh JF, Tasi SC,et al. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma. Lung, 2000,178( 2):75.
  • 2Cetin T,Oguz A,Algan P,et al.The use of tissue polypeptide specific antigen as a marker in liver diseases.Turk J Gastroenterol, 2003,14 (3):177.
  • 3Einarsson R, Rydlander L.Tissue polypeptide specific antigen(TPS)detects a specific epitope structure on human cytokeratin. Anticancer Res , 1997,17:3121.
  • 4Ahmed Ml, Salahy EE, Tawfiq H, et al. Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: Relationship with prognosis.Dis Markers,2004,20(6):333.
  • 5Sliwowska I, Kopczynski Z, Grodecka-Gazdecka S. Diagnostic value of measuring serum CA 15-3,TPA,and TPS in women with breast cancer.Postepy Hig Med Dosw (Online), 2006,60:295.
  • 6Monteiro E, Varzim G, Crespo M, et al.Cyfra 21.1, TPS and SCC in squamous cell carcinoma of larynx.An Otorrinolaringol Ibero Am, 2003,30(5):467.
  • 7Di Carlo A, Terracciano D, Mariano A, et al.Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors. Oncol Rep,2006 , 15(5):1321.
  • 8Szpurek D, Moszynski R, Smolen A, et al. Artificial neural network computer prediction of ovarian malignancy in women with adnexal masses. Int J Gynaecol Obstet,2005 ,89(2):108.
  • 9韩松,陶义训.ELISA中阴性本底的形成原因和消除方法[J].上海医学检验杂志,1990,5(2):118-120. 被引量:6
  • 10高冬花.七种酶在血清与血浆中活性的比较[J].大理医学院学报,2000,9(4):24-24. 被引量:1

二级参考文献9

  • 1Pujol JL,Grenier J,Parrat E,et al.Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS[].American Journal of Respiratory and Critical Care Medicine.1996
  • 2Ho YJ,Hsieh JF,Tasi SC,et al.Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma[].Lung.2000
  • 3Abbasciano V,Sartori S,Trevisani L,et al.Neuron-specific enolase,thymidine kinase, and tissue polypeptide-specific antigen in diagnosis and response to chemotherapy of small-cell lung cancer[].Cancer Detection and Prevention.1999
  • 4Molina R,Torres MD,Moragas M,et al.TPS in patients with head and neck maliganancies: comparison with SCC[].Anticancer Research.1995
  • 5Theyer G,Durer A,Theyer U,et al.Measurements of free and total PSA, TPS and CYFRA 21-1 in prostate cancer patientc under intermittent androgen suppression therapy[].Prostate.1999
  • 6Rydlander L,Ziegler E,Bergman T,et al.Molecular characterization of a tissue polypeptide specific antigen(TPS) epitope and its elationship to human cytokeratin 18[].European Journal of Biochemistry.1996
  • 7Kim F,Logothetis CJ,Morota K,et al.Serologic tumor marker, clinical biology, and therapy of prostatic carcinoma[].Urologic Clinics of North America.1999
  • 8Glimelius B,Hoffman K,Einarsson R,et al.Monitoring palliative chemotherapy in advanced gastrointestinal cancer using serial tissue polypeptide specific antigen(TPS) measurements[].Acta Oncologica.1996
  • 9郭玮,潘柏申.4142名正常人血清ALT测定结果及其参考区间[J].上海医学检验杂志,1997,12(3):133-134. 被引量:4

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部